The increasing production of biologic medicines is creating demand for advanced purification technologies across the pharmaceutical and biotechnology industries. Mixed mode chromatography resins combine multiple interaction mechanisms, allowing manufacturers to separate and purify complex biological molecules with greater selectivity and flexibility. This makes them increasingly relevant to modern downstream processing.

According to Market Research Future, the mixed mode chromatography resin market was valued at USD 2.872 billion in 2024 and is projected to reach USD 4.441 billion by 2035. The market is expected to grow at a CAGR of 4.04% from 2025 to 2035.

Biopharmaceutical production is one of the most important factors supporting demand. Monoclonal antibodies, recombinant proteins, vaccines, and other biologics require highly efficient purification processes to achieve the desired purity and quality.

Mixed mode resins are useful because they can interact with target molecules through combinations of ionic, hydrophobic, and other mechanisms. This can provide additional selectivity compared with conventional single-mode chromatography techniques.

Protein purification represents the largest application segment in the MRFR market segmentation. Increasing production of therapeutic proteins is therefore expected to support continued resin demand.

Polymeric resins currently lead the resin-type segment. Their versatility, established manufacturing processes, and broad range of applications make them widely used in purification workflows.

Process optimization is another major market trend. Pharmaceutical manufacturers are looking for technologies that can reduce purification steps, improve recovery, and increase overall process efficiency.

North America remains the largest regional market, supported by its strong pharmaceutical and biotechnology sectors. Asia-Pacific is identified as the fastest-growing region as biopharmaceutical manufacturing capacity expands.

Automation is also becoming increasingly important. Automated chromatography systems can improve process consistency and enable better control over purification operations.

As biologic drug development continues to expand, the need for selective and adaptable purification technologies is expected to remain strong. Mixed mode chromatography resins can play an important role in supporting efficient downstream processing through 2035.